claim
Clinical trials for treating amyotrophic lateral sclerosis with stem cells, such as NCT05306457, have been completed and yielded desired results using autologous mesenchymal stem cells, endogenous mesenchymal stem cell mobilization, neural stem cells, and T-cell vaccination combined with mesenchymal stem cell and neural stem cell therapy.

Authors

Sources

Referenced by nodes (3)